These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Coronary risk in patients with endstage renal disease: interaction of hypertension with hyperlipidemia. Goldberg AP; Tindira C; Harter HR J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S257-61. PubMed ID: 6177969 [No Abstract] [Full Text] [Related]
5. [Cross-sectional study of arterial pressure and serum lipids in smoking and non-smoking coronary disease patients]. Vlaicu R; Macavei E; Paţiu I Med Interna (Bucur); 1971 Aug; 23(8):925-30. PubMed ID: 5093851 [No Abstract] [Full Text] [Related]
6. Risk factors for ischaemic heart-disease in normal men aged 40. Edinburgh-Stockholm Study. Logan RL; Riemersma RA; Thomson M; Oliver MF; Olsson AG; Walldius G; Rössner S; Kaijser L; Callmer E; Carlson LA; Lockerbie L; Lutz W Lancet; 1978 May; 1(8071):949-54. PubMed ID: 76888 [No Abstract] [Full Text] [Related]
7. Preventive medicine in primary care: management of hyperlipidaemia. Lewis B Br J Gen Pract; 1992 Feb; 42(355):47-50. PubMed ID: 1493003 [No Abstract] [Full Text] [Related]
8. The critical role of the endothelial cell in acute coronary events. Futterman LG; Lemberg L Am J Crit Care; 2001 May; 10(3):191-9. PubMed ID: 11340742 [No Abstract] [Full Text] [Related]
12. [Study on the interaction between hypertension, smoking and the disorder of lipids metabolism in the coronary artery disease]. He Y Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Apr; 13(2):101-5. PubMed ID: 1394381 [TBL] [Abstract][Full Text] [Related]
13. [Significance of hyperlipemia and hypertension in coronary heart disease (author's transl)]. Ogino K Rinsho Byori; 1975 Jan; 23(1):25-30. PubMed ID: 1168270 [No Abstract] [Full Text] [Related]
15. The role of lipids and blood pressure in the development of coronary heart disease. The Framingham study. Kannel WB G Ital Cardiol; 1974; 4(1):123-37. PubMed ID: 4824624 [No Abstract] [Full Text] [Related]
16. Value of predisposing factors in ischaemic heart disease. Misra NP; Manoria PC Indian Heart J Teach Ser; 1980; (9):357-63. PubMed ID: 7309071 [No Abstract] [Full Text] [Related]
17. Which lipid fraction is the target and how often should this be monitored? Thompson G Heart; 2010 Mar; 96(6):413-4. PubMed ID: 20299412 [No Abstract] [Full Text] [Related]
18. Hypertension as a risk factor for the development of coronary heart disease. Salky N J Tenn Dent Assoc; 1978 Jan; 58(1):11-2. PubMed ID: 285307 [No Abstract] [Full Text] [Related]
19. [Natural history of coronary atherosclerosis in Iranian workers]. Daneche Pajouh M; Montazami K; Hedayat C; Kamali P; Pirouzmande B Arch Mal Coeur Vaiss; 1973 Sep; 66(9):1201-10. PubMed ID: 4207465 [No Abstract] [Full Text] [Related]
20. Focus on hyperlipidaemia. Rational and practical guidelines for reducing the risk of coronary heart disease. DiBianco R S Afr Med J; 1992 Feb; Suppl():1-9. PubMed ID: 1542809 [No Abstract] [Full Text] [Related] [Next] [New Search]